ReviewOsteoarthritis and cartilage open2026
The gut microbiome's role in the development and progression of post-traumatic osteoarthritis: A systematic review.
Review in Osteoarthritis and cartilage open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Gut microbiome dysbiosis is linked to osteoarthritis (OA), but its specific association with post-traumatic osteoarthritis (PTOA) is less understood. This systematic review synthesizes evidence linking PTOA and the gut microbiome to clarify its role in PTOA pathogenesis. Method: Literature searches were conducted in PubMed, Embase, SPORTDiscus, and Web of Science through October 2025. Quantitative, original human and animal studies examining associations between the presence/severity of PTOA and gut microbiota composition and diversity were included. These measures were extracted and synthesized. Risk of bias was assessed using ROBINS-I for non-randomized and RoB 2 for randomized studies (PROSPERO registration: CRD42024496152). Results: Thirteen studies met inclusion criteria, all utilizing small animal PTOA models. Generally, they found significant gut microbiome differences between PTOA and control groups. Collectively, these preclinical studies provided evidence that the gut microbiome can influence biological processes underlying PTOA, particularly via inflammatory and metabolic pathways, and vice versa. Two studies examined exercise, showing it can reduce PTOA severity by slowing articular cartilage degeneration and subchondral bone loss, increase microbiome diversity, and mitigate negative effects of poor diet. Conclusions: Current literature from animal models suggests the gut microbiome may play a role in PTOA development and progression, emphasizing a bidirectional "gut-joint axis." Traumatic joint injuries may lead to systemic inflammation affecting the gut microbiome, which may exacerbate joint inflammation and PTOA progression. Significant gaps remain, particularly the lack of human studies. Future research should prioritize clinically relevant animal models and human studies to elucidate the gut microbiome's role in PTOA pathogenesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.